Xact Kapitalforvaltning AB lifted its position in Waters Co. (NYSE:WAT) by 13.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,496 shares of the medical instruments supplier’s stock after acquiring an additional 1,742 shares during the period. Xact Kapitalforvaltning AB’s holdings in Waters were worth $3,649,000 at the end of the most recent quarter.
Several other large investors have also recently made changes to their positions in WAT. Stone Ridge Asset Management LLC lifted its holdings in shares of Waters by 7.0% during the fourth quarter. Stone Ridge Asset Management LLC now owns 2,535 shares of the medical instruments supplier’s stock worth $478,000 after buying an additional 166 shares in the last quarter. Nisa Investment Advisors LLC lifted its holdings in shares of Waters by 4.2% during the first quarter. Nisa Investment Advisors LLC now owns 46,494 shares of the medical instruments supplier’s stock worth $11,703,000 after buying an additional 1,880 shares in the last quarter. Kinneret Advisory LLC acquired a new stake in shares of Waters during the fourth quarter worth $1,055,000. Ontario Teachers Pension Plan Board lifted its holdings in shares of Waters by 6.7% during the fourth quarter. Ontario Teachers Pension Plan Board now owns 173,146 shares of the medical instruments supplier’s stock worth $32,664,000 after buying an additional 10,815 shares in the last quarter. Finally, IFM Investors Pty Ltd raised its stake in Waters by 10.5% in the first quarter. IFM Investors Pty Ltd now owns 4,985 shares of the medical instruments supplier’s stock valued at $1,255,000 after purchasing an additional 472 shares in the last quarter. Institutional investors and hedge funds own 92.57% of the company’s stock.
Shares of NYSE:WAT traded up $1.77 during midday trading on Friday, hitting $215.24. 810,218 shares of the stock were exchanged, compared to its average volume of 626,179. The business’s 50-day simple moving average is $207.91. Waters Co. has a 12 month low of $167.93 and a 12 month high of $255.21. The firm has a market cap of $14.66 billion, a PE ratio of 25.96, a price-to-earnings-growth ratio of 2.23 and a beta of 1.08. The company has a debt-to-equity ratio of 1.15, a current ratio of 3.44 and a quick ratio of 2.89.
A number of research firms recently commented on WAT. Zacks Investment Research downgraded Waters from a “strong-buy” rating to a “hold” rating in a research note on Friday, April 12th. ValuEngine downgraded Waters from a “buy” rating to a “hold” rating in a research note on Wednesday, April 24th. UBS Group dropped their price target on Waters from $248.00 to $230.00 and set a “neutral” rating for the company in a research note on Wednesday, April 24th. Cleveland Research downgraded Waters from a “neutral” rating to an “underperform” rating in a research note on Wednesday, June 12th. Finally, Barclays lowered their target price on Waters from $218.00 to $210.00 and set an “equal weight” rating for the company in a research note on Wednesday, April 24th. Four research analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the company. Waters presently has a consensus rating of “Hold” and an average target price of $208.71.
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Read More: How To Calculate Debt-to-Equity Ratio
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.